- Home
- LXEO vs VALU Comparison
LXEO vs VALU Comparison
Compare LXEO & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LXEO | VALU |
|---|---|---|
| Founded | 2017 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.1M | 311.5M |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LXEO | VALU |
|---|---|---|
| Price | $4.69 | $35.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.44 | N/A |
| AVG Volume (30 Days) | ★ 803.0K | 1.9K |
| Earning Date | 05-06-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 3.72% |
| EPS Growth | ★ 39.81 | 8.91 |
| EPS | N/A | ★ 1.92 |
| Revenue | $654,000.00 | ★ $36,257,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.95 |
| Revenue Growth | N/A | ★ 1.08 |
| 52 Week Low | $3.60 | $32.00 |
| 52 Week High | $10.99 | $40.50 |
Technical Indicators
Market Signals| Indicator | LXEO | VALU |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 69.10 |
| Support Level | $4.44 | $36.98 |
| Resistance Level | $5.34 | $38.21 |
| Average True Range (ATR) | 0.35 | 1.04 |
| MACD | 0.08 | 0.39 |
| Stochastic Oscillator | 57.25 | 100.00 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.